Tolcapone is a selective and reversible catechol-O-methyltransferase (COMT) inhibitor primarily utilized as an adjunct treatment for Parkinson’s disease. By inhibiting the peripheral conversion of levodopa… Read more










Tolcapone is a selective and reversible catechol-O-methyltransferase (COMT) inhibitor primarily utilized as an adjunct treatment for Parkinson’s disease. By inhibiting the peripheral conversion of levodopa to dopamine, this pharmaceutical agent helps manage symptoms such as tremors, rigidity, and muscle spasms by increasing the bioavailability and central nervous system levels of levodopa. To ensure accurate assessment and compliance in clinical and research settings, high-quality reference standards are essential. This category provides comprehensive analytical tools, including Tolcapone API, pharmacopeial and non-pharmacopeial impurities such as 3-O-methyl and denitro derivatives, and major metabolites like Tolcapone 3-beta-D-glucuronide. Laboratories rely on these materials and stable isotope-labelled compounds for precise impurity profiling, method validation, and rigorous quality control protocols. Utilizing these specialized reference materials allows scientists to maintain stringent analytical standards throughout the development and manufacturing processes of Parkinson's disease therapies.